On January 12, 2024, Scinai Immunotherapeutics Ltd. closed the transaction. The transaction included participation from a single investor
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 USD | -3.30% | +0.09% | -26.10% |
1st Jan change | Capi. | |
---|---|---|
-26.10% | 1.98M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- SCNI Stock
- News Scinai Immunotherapeutics Ltd.
- Scinai Immunotherapeutics Ltd. announced that it has received $1.694259 million in funding